technetium tc 99m pentetate has been researched along with deamino arginine vasopressin in 1 studies
| Studies (technetium tc 99m pentetate) | Trials (technetium tc 99m pentetate) | Recent Studies (post-2010) (technetium tc 99m pentetate) | Studies (deamino arginine vasopressin) | Trials (deamino arginine vasopressin) | Recent Studies (post-2010) (deamino arginine vasopressin) |
|---|---|---|---|---|---|
| 3,336 | 275 | 394 | 4,396 | 516 | 1,016 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Imamine, H; Kobayashi, M; Mizuno, H; Ohro, Y; Sasaki, S; Sugiyama, Y; Togari, H; Uchida, S | 1 |
1 other study(ies) available for technetium tc 99m pentetate and deamino arginine vasopressin
| Article | Year |
|---|---|
Clinical characteristics of eight patients with congenital nephrogenic diabetes insipidus.
Topics: Adolescent; Adult; Age of Onset; Antihypertensive Agents; Child; Child, Preschool; Deamino Arginine Vasopressin; Diabetes Insipidus, Nephrogenic; Diuretics; Glomerular Filtration Rate; Hemostatics; Humans; Male; Osmolar Concentration; Radiopharmaceuticals; Receptors, Vasopressin; Renal Agents; Saline Solution, Hypertonic; Sodium Chloride Symporter Inhibitors; Technetium Tc 99m Pentetate; Trichlormethiazide | 2004 |